schliessen

Filtern

 

Bibliotheken

Cover Image

Frequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance

Cardiac troponin T level predicts a gradient risk for death in patients using hemodialysis. We used cardiovascular magnetic resonance (CMR) to determine whether an asymptomatic increase of troponin T in patients using hemodialysis is associated with subclinical myocardial infarction (MI). Twenty-six... Full description

Journal Title: The American journal of cardiology 2007, Vol.100 (5), p.885-889
Main Author: deFilippi, Christopher R., MD
Other Authors: Thorn, Eric M., MD , Aggarwal, Monica, MD , Joy, Abel, MD , Christenson, Robert H., PhD , Duh, Show-Hong, PhD , Jeudy, Jean, MD , Beache, Garth, MD
Format: Electronic Article Electronic Article
Language: English
Subjects:
Abridged Index Medicus
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cardiac patients
Cardiology
Cardiology. Vascular system
Cardiovascular
Contrast Media
Cross-Sectional Studies
Diabetics
Echocardiography
Emergency and intensive care: renal failure. Dialysis management
Female
Gadolinium
Gadolinium oxide
Heart attack
Heart attacks
Heart Ventricles - pathology
Hemodialysis
Humans
Hypertrophy, Left Ventricular - blood
Hypertrophy, Left Ventricular - diagnosis
Image Processing, Computer-Assisted
Intensive care medicine
Lactate dehydrogenase
Magnetic Resonance Imaging
Male
Medical research
Medical sciences
Medicine, Experimental
Middle Aged
Myocardial Infarction - blood
Myocardial Infarction - diagnosis
Myocardium - pathology
NMR
Nuclear magnetic resonance
Renal Dialysis
Risk Factors
Stroke Volume - physiology
Troponin T - blood
Publisher: New York, NY: Elsevier Inc
ID: ISSN: 0002-9149
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_68199642
title: Frequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance
format: Article
creator:
  • deFilippi, Christopher R., MD
  • Thorn, Eric M., MD
  • Aggarwal, Monica, MD
  • Joy, Abel, MD
  • Christenson, Robert H., PhD
  • Duh, Show-Hong, PhD
  • Jeudy, Jean, MD
  • Beache, Garth, MD
subjects:
  • Abridged Index Medicus
  • Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
  • Biological and medical sciences
  • Cardiac patients
  • Cardiology
  • Cardiology. Vascular system
  • Cardiovascular
  • Contrast Media
  • Cross-Sectional Studies
  • Diabetics
  • Echocardiography
  • Emergency and intensive care: renal failure. Dialysis management
  • Female
  • Gadolinium
  • Gadolinium oxide
  • Heart attack
  • Heart attacks
  • Heart Ventricles - pathology
  • Hemodialysis
  • Humans
  • Hypertrophy, Left Ventricular - blood
  • Hypertrophy, Left Ventricular - diagnosis
  • Image Processing, Computer-Assisted
  • Intensive care medicine
  • Lactate dehydrogenase
  • Magnetic Resonance Imaging
  • Male
  • Medical research
  • Medical sciences
  • Medicine, Experimental
  • Middle Aged
  • Myocardial Infarction - blood
  • Myocardial Infarction - diagnosis
  • Myocardium - pathology
  • NMR
  • Nuclear magnetic resonance
  • Renal Dialysis
  • Risk Factors
  • Stroke Volume - physiology
  • Troponin T - blood
ispartof: The American journal of cardiology, 2007, Vol.100 (5), p.885-889
description: Cardiac troponin T level predicts a gradient risk for death in patients using hemodialysis. We used cardiovascular magnetic resonance (CMR) to determine whether an asymptomatic increase of troponin T in patients using hemodialysis is associated with subclinical myocardial infarction (MI). Twenty-six patients using long-term hemodialysis (49 ± 12 years of age, 19 men, 8 diabetics) with left ventricular (LV) ejection fraction >40% and no known coronary artery disease were selected based on a low-risk troponin T level ≤0.03 ng/ml (median 0.02, interquartile range 0.00 to 0.02, n = 13) and high-risk troponin T level ≥0.07 ng/ml (median 0.15, interquartile range 0.09 to 0.19, n = 13). All underwent CMR imaging for LV mass and for MI by late gadolinium enhancement. Between high- and low-risk patients using hemodialysis, there were no differences in age, gender, ethnicity, or diabetes mellitus. Of the high-risk patients, 3 (23%, 95% confidence interval [CI] 5 to 54) had MI by late gadolinium enhancement versus 0 (0%, 95% CI 0 to 25) low-risk patients (p = 0.22). A diffuse, midwall late gadolinium enhancement pattern was seen in 1 high-risk patient (8%) versus 0 low-risk patient (0%, 95% CI 0 to 25, p = 0.97). Height-adjusted LV mass and LV hypertrophy were not significantly different between high-risk (62 ± 26 g/m2.7 , LV hypertrophy, n = 7, 54%) and low-risk (54 ± 20 g/m2.7 , LV hypertrophy, n = 5, 39%) patients (p = 0.37 for LV mass, p = 0.69 for LV hypertrophy). In conclusion, MI detected by CMR is present in few patients on hemodialysis with high troponin T levels and absent in the setting of very low troponin T levels, suggesting that additional myocardial pathologies cause increased troponin T in patients using hemodialysis.
language: eng
source:
identifier: ISSN: 0002-9149
fulltext: no_fulltext
issn:
  • 0002-9149
  • 1879-1913
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.2919016
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_68199642
sourceformatXML
sourcesystemPC
galeidA168096305
sourcerecordidA168096305
originalsourceidFETCH-LOGICAL-c504t-34a0d63b1baebed758ec8d3e0385ee9bbb4b92e51c709722bf59996cc7f1829f0
addsrcrecordideNqFkk9v1DAQxSMEotvCRwBZSHDbMHb-WkhF1aqlSEUgupwtx5kUL4m92MlKe-8HZ5ZdtdJeqhwSO783ejNvkuQNh5QDLz-uUj2sjA5tKgCqFPIURP0smfG6knMuefY8mQGAmEuey5PkNMYVHTkvypfJCa8qLrNMzpL7q4B_J3Rmy7Rr2UJPEZnv6CO0Vhu2DH7tnXVsyS573OjResfouPgd6Nqwaxw8gf022sh-0G90Y2Rd8AO7Had2-1DLb3Q0U68D-6bvHI6k_YnRO-0MvkpedLqP-PrwPkt-XV0uF9fzm-9fvi4ubuamgHycZ7mGtswa3mhssK2KGk3dZghZXSDKpmnyRgosuKlAVkI0XSGlLI2pOl4L2cFZ8mFfdx08NR1HNdhosO-1Qz9FVdac-FwQ-O4IXPkpOPKmRAZZJUrOCUr30J3uUVnX-TFoQ0-LgzXeYWfp_oKXNcgyg4IExV5ggo8xYKfWwQ46bBUHtQtVrdQhVLULVUGuKFTSvT24mZoB20fVIUUC3h8AmrHuu0BDtfGRk5BDLXZtfToyYOz4P1JybvsnbXzeq5Ei2lgMKhqK22BrA5pRtd4-WeH8qILpLW2R7v_gFuPDjLmKQoG63e3vbn2hAg6SGvgHei_r8g
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid230372611
display
typearticle
titleFrequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance
creatordeFilippi, Christopher R., MD ; Thorn, Eric M., MD ; Aggarwal, Monica, MD ; Joy, Abel, MD ; Christenson, Robert H., PhD ; Duh, Show-Hong, PhD ; Jeudy, Jean, MD ; Beache, Garth, MD
creatorcontribdeFilippi, Christopher R., MD ; Thorn, Eric M., MD ; Aggarwal, Monica, MD ; Joy, Abel, MD ; Christenson, Robert H., PhD ; Duh, Show-Hong, PhD ; Jeudy, Jean, MD ; Beache, Garth, MD
descriptionCardiac troponin T level predicts a gradient risk for death in patients using hemodialysis. We used cardiovascular magnetic resonance (CMR) to determine whether an asymptomatic increase of troponin T in patients using hemodialysis is associated with subclinical myocardial infarction (MI). Twenty-six patients using long-term hemodialysis (49 ± 12 years of age, 19 men, 8 diabetics) with left ventricular (LV) ejection fraction >40% and no known coronary artery disease were selected based on a low-risk troponin T level ≤0.03 ng/ml (median 0.02, interquartile range 0.00 to 0.02, n = 13) and high-risk troponin T level ≥0.07 ng/ml (median 0.15, interquartile range 0.09 to 0.19, n = 13). All underwent CMR imaging for LV mass and for MI by late gadolinium enhancement. Between high- and low-risk patients using hemodialysis, there were no differences in age, gender, ethnicity, or diabetes mellitus. Of the high-risk patients, 3 (23%, 95% confidence interval [CI] 5 to 54) had MI by late gadolinium enhancement versus 0 (0%, 95% CI 0 to 25) low-risk patients (p = 0.22). A diffuse, midwall late gadolinium enhancement pattern was seen in 1 high-risk patient (8%) versus 0 low-risk patient (0%, 95% CI 0 to 25, p = 0.97). Height-adjusted LV mass and LV hypertrophy were not significantly different between high-risk (62 ± 26 g/m2.7 , LV hypertrophy, n = 7, 54%) and low-risk (54 ± 20 g/m2.7 , LV hypertrophy, n = 5, 39%) patients (p = 0.37 for LV mass, p = 0.69 for LV hypertrophy). In conclusion, MI detected by CMR is present in few patients on hemodialysis with high troponin T levels and absent in the setting of very low troponin T levels, suggesting that additional myocardial pathologies cause increased troponin T in patients using hemodialysis.
identifier
0ISSN: 0002-9149
1EISSN: 1879-1913
2DOI: 10.1016/j.amjcard.2007.04.028
3PMID: 17719339
4CODEN: AJCDAG
languageeng
publisherNew York, NY: Elsevier Inc
subjectAbridged Index Medicus ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cardiac patients ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Contrast Media ; Cross-Sectional Studies ; Diabetics ; Echocardiography ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Gadolinium ; Gadolinium oxide ; Heart attack ; Heart attacks ; Heart Ventricles - pathology ; Hemodialysis ; Humans ; Hypertrophy, Left Ventricular - blood ; Hypertrophy, Left Ventricular - diagnosis ; Image Processing, Computer-Assisted ; Intensive care medicine ; Lactate dehydrogenase ; Magnetic Resonance Imaging ; Male ; Medical research ; Medical sciences ; Medicine, Experimental ; Middle Aged ; Myocardial Infarction - blood ; Myocardial Infarction - diagnosis ; Myocardium - pathology ; NMR ; Nuclear magnetic resonance ; Renal Dialysis ; Risk Factors ; Stroke Volume - physiology ; Troponin T - blood
ispartofThe American journal of cardiology, 2007, Vol.100 (5), p.885-889
rights
0Elsevier Inc.
12007 Elsevier Inc.
22007 INIST-CNRS
3COPYRIGHT 2007 Elsevier B.V.
4Copyright Elsevier Sequoia S.A. Sep 1, 2007
lds50peer_reviewed
citedbyFETCH-LOGICAL-c504t-34a0d63b1baebed758ec8d3e0385ee9bbb4b92e51c709722bf59996cc7f1829f0
citesFETCH-LOGICAL-c504t-34a0d63b1baebed758ec8d3e0385ee9bbb4b92e51c709722bf59996cc7f1829f0
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19040822$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17719339$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0deFilippi, Christopher R., MD
1Thorn, Eric M., MD
2Aggarwal, Monica, MD
3Joy, Abel, MD
4Christenson, Robert H., PhD
5Duh, Show-Hong, PhD
6Jeudy, Jean, MD
7Beache, Garth, MD
title
0Frequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance
1The American journal of cardiology
addtitleAm J Cardiol
descriptionCardiac troponin T level predicts a gradient risk for death in patients using hemodialysis. We used cardiovascular magnetic resonance (CMR) to determine whether an asymptomatic increase of troponin T in patients using hemodialysis is associated with subclinical myocardial infarction (MI). Twenty-six patients using long-term hemodialysis (49 ± 12 years of age, 19 men, 8 diabetics) with left ventricular (LV) ejection fraction >40% and no known coronary artery disease were selected based on a low-risk troponin T level ≤0.03 ng/ml (median 0.02, interquartile range 0.00 to 0.02, n = 13) and high-risk troponin T level ≥0.07 ng/ml (median 0.15, interquartile range 0.09 to 0.19, n = 13). All underwent CMR imaging for LV mass and for MI by late gadolinium enhancement. Between high- and low-risk patients using hemodialysis, there were no differences in age, gender, ethnicity, or diabetes mellitus. Of the high-risk patients, 3 (23%, 95% confidence interval [CI] 5 to 54) had MI by late gadolinium enhancement versus 0 (0%, 95% CI 0 to 25) low-risk patients (p = 0.22). A diffuse, midwall late gadolinium enhancement pattern was seen in 1 high-risk patient (8%) versus 0 low-risk patient (0%, 95% CI 0 to 25, p = 0.97). Height-adjusted LV mass and LV hypertrophy were not significantly different between high-risk (62 ± 26 g/m2.7 , LV hypertrophy, n = 7, 54%) and low-risk (54 ± 20 g/m2.7 , LV hypertrophy, n = 5, 39%) patients (p = 0.37 for LV mass, p = 0.69 for LV hypertrophy). In conclusion, MI detected by CMR is present in few patients on hemodialysis with high troponin T levels and absent in the setting of very low troponin T levels, suggesting that additional myocardial pathologies cause increased troponin T in patients using hemodialysis.
subject
0Abridged Index Medicus
1Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
2Biological and medical sciences
3Cardiac patients
4Cardiology
5Cardiology. Vascular system
6Cardiovascular
7Contrast Media
8Cross-Sectional Studies
9Diabetics
10Echocardiography
11Emergency and intensive care: renal failure. Dialysis management
12Female
13Gadolinium
14Gadolinium oxide
15Heart attack
16Heart attacks
17Heart Ventricles - pathology
18Hemodialysis
19Humans
20Hypertrophy, Left Ventricular - blood
21Hypertrophy, Left Ventricular - diagnosis
22Image Processing, Computer-Assisted
23Intensive care medicine
24Lactate dehydrogenase
25Magnetic Resonance Imaging
26Male
27Medical research
28Medical sciences
29Medicine, Experimental
30Middle Aged
31Myocardial Infarction - blood
32Myocardial Infarction - diagnosis
33Myocardium - pathology
34NMR
35Nuclear magnetic resonance
36Renal Dialysis
37Risk Factors
38Stroke Volume - physiology
39Troponin T - blood
issn
00002-9149
11879-1913
fulltextfalse
rsrctypearticle
creationdate2007
recordtypearticle
recordideNqFkk9v1DAQxSMEotvCRwBZSHDbMHb-WkhF1aqlSEUgupwtx5kUL4m92MlKe-8HZ5ZdtdJeqhwSO783ejNvkuQNh5QDLz-uUj2sjA5tKgCqFPIURP0smfG6knMuefY8mQGAmEuey5PkNMYVHTkvypfJCa8qLrNMzpL7q4B_J3Rmy7Rr2UJPEZnv6CO0Vhu2DH7tnXVsyS573OjResfouPgd6Nqwaxw8gf022sh-0G90Y2Rd8AO7Had2-1DLb3Q0U68D-6bvHI6k_YnRO-0MvkpedLqP-PrwPkt-XV0uF9fzm-9fvi4ubuamgHycZ7mGtswa3mhssK2KGk3dZghZXSDKpmnyRgosuKlAVkI0XSGlLI2pOl4L2cFZ8mFfdx08NR1HNdhosO-1Qz9FVdac-FwQ-O4IXPkpOPKmRAZZJUrOCUr30J3uUVnX-TFoQ0-LgzXeYWfp_oKXNcgyg4IExV5ggo8xYKfWwQ46bBUHtQtVrdQhVLULVUGuKFTSvT24mZoB20fVIUUC3h8AmrHuu0BDtfGRk5BDLXZtfToyYOz4P1JybvsnbXzeq5Ei2lgMKhqK22BrA5pRtd4-WeH8qILpLW2R7v_gFuPDjLmKQoG63e3vbn2hAg6SGvgHei_r8g
startdate2007
enddate2007
creator
0deFilippi, Christopher R., MD
1Thorn, Eric M., MD
2Aggarwal, Monica, MD
3Joy, Abel, MD
4Christenson, Robert H., PhD
5Duh, Show-Hong, PhD
6Jeudy, Jean, MD
7Beache, Garth, MD
general
0Elsevier Inc
1Elsevier
2Elsevier B.V
3Elsevier Limited
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
9BSHEE
107QO
117TS
128FD
13FR3
14K9.
15P64
167X8
sort
creationdate2007
titleFrequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance
authordeFilippi, Christopher R., MD ; Thorn, Eric M., MD ; Aggarwal, Monica, MD ; Joy, Abel, MD ; Christenson, Robert H., PhD ; Duh, Show-Hong, PhD ; Jeudy, Jean, MD ; Beache, Garth, MD
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c504t-34a0d63b1baebed758ec8d3e0385ee9bbb4b92e51c709722bf59996cc7f1829f0
rsrctypearticles
prefilterarticles
languageeng
creationdate2007
topic
0Abridged Index Medicus
1Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
2Biological and medical sciences
3Cardiac patients
4Cardiology
5Cardiology. Vascular system
6Cardiovascular
7Contrast Media
8Cross-Sectional Studies
9Diabetics
10Echocardiography
11Emergency and intensive care: renal failure. Dialysis management
12Female
13Gadolinium
14Gadolinium oxide
15Heart attack
16Heart attacks
17Heart Ventricles - pathology
18Hemodialysis
19Humans
20Hypertrophy, Left Ventricular - blood
21Hypertrophy, Left Ventricular - diagnosis
22Image Processing, Computer-Assisted
23Intensive care medicine
24Lactate dehydrogenase
25Magnetic Resonance Imaging
26Male
27Medical research
28Medical sciences
29Medicine, Experimental
30Middle Aged
31Myocardial Infarction - blood
32Myocardial Infarction - diagnosis
33Myocardium - pathology
34NMR
35Nuclear magnetic resonance
36Renal Dialysis
37Risk Factors
38Stroke Volume - physiology
39Troponin T - blood
toplevelpeer_reviewed
creatorcontrib
0deFilippi, Christopher R., MD
1Thorn, Eric M., MD
2Aggarwal, Monica, MD
3Joy, Abel, MD
4Christenson, Robert H., PhD
5Duh, Show-Hong, PhD
6Jeudy, Jean, MD
7Beache, Garth, MD
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8Academic OneFile (A&I only)
9Biotechnology Research Abstracts
10Physical Education Index
11Technology Research Database
12Engineering Research Database
13ProQuest Health & Medical Complete (Alumni)
14Biotechnology and BioEngineering Abstracts
15MEDLINE - Academic
jtitleThe American journal of cardiology
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0deFilippi, Christopher R., MD
1Thorn, Eric M., MD
2Aggarwal, Monica, MD
3Joy, Abel, MD
4Christenson, Robert H., PhD
5Duh, Show-Hong, PhD
6Jeudy, Jean, MD
7Beache, Garth, MD
formatjournal
genrearticle
ristypeJOUR
atitleFrequency and Cause of Cardiac Troponin T Elevation in Chronic Hemodialysis Patients from Study of Cardiovascular Magnetic Resonance
jtitleThe American journal of cardiology
addtitleAm J Cardiol
date2007
risdate2007
volume100
issue5
spage885
epage889
pages885-889
issn0002-9149
eissn1879-1913
codenAJCDAG
abstractCardiac troponin T level predicts a gradient risk for death in patients using hemodialysis. We used cardiovascular magnetic resonance (CMR) to determine whether an asymptomatic increase of troponin T in patients using hemodialysis is associated with subclinical myocardial infarction (MI). Twenty-six patients using long-term hemodialysis (49 ± 12 years of age, 19 men, 8 diabetics) with left ventricular (LV) ejection fraction >40% and no known coronary artery disease were selected based on a low-risk troponin T level ≤0.03 ng/ml (median 0.02, interquartile range 0.00 to 0.02, n = 13) and high-risk troponin T level ≥0.07 ng/ml (median 0.15, interquartile range 0.09 to 0.19, n = 13). All underwent CMR imaging for LV mass and for MI by late gadolinium enhancement. Between high- and low-risk patients using hemodialysis, there were no differences in age, gender, ethnicity, or diabetes mellitus. Of the high-risk patients, 3 (23%, 95% confidence interval [CI] 5 to 54) had MI by late gadolinium enhancement versus 0 (0%, 95% CI 0 to 25) low-risk patients (p = 0.22). A diffuse, midwall late gadolinium enhancement pattern was seen in 1 high-risk patient (8%) versus 0 low-risk patient (0%, 95% CI 0 to 25, p = 0.97). Height-adjusted LV mass and LV hypertrophy were not significantly different between high-risk (62 ± 26 g/m2.7 , LV hypertrophy, n = 7, 54%) and low-risk (54 ± 20 g/m2.7 , LV hypertrophy, n = 5, 39%) patients (p = 0.37 for LV mass, p = 0.69 for LV hypertrophy). In conclusion, MI detected by CMR is present in few patients on hemodialysis with high troponin T levels and absent in the setting of very low troponin T levels, suggesting that additional myocardial pathologies cause increased troponin T in patients using hemodialysis.
copNew York, NY
pubElsevier Inc
pmid17719339
doi10.1016/j.amjcard.2007.04.028